Home » Tenders » Europe » Poland » Siltuximab Medicinal Product as Part of the B.131 Drug Program Tender, Poland - 100956967

Siltuximab Medicinal Product as Part of the B.131 Drug Program Tender, Poland - 100956967

Download Documents

UNIVERSITY CLINICAL HOSPITAL IN POZNAŃ has floated a tender for Siltuximab Medicinal Product as Part of the B.131 Drug Program. The project location is Poland and the tender is closing on 16 May 2024. The tender notice number is 2024/BZP 00312768/01, while the TOT Ref Number is 100956967. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Poland

Summary : Siltuximab Medicinal Product as Part of the B.131 Drug Program

Deadline : 16 May 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100956967

Document Ref. No. : 2024/BZP 00312768/01

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : PLN 2819341

Purchaser's Detail

Purchaser : UNIVERSITY CLINICAL HOSPITAL IN POZNAŃ
Street Stanisława Przybyszewskiego 49, Poznań, 60-355, Wielkopolskie, Poland
Tel: 61 8691100
Poland
Email :dzp@usk.poznan.pl
URL :www.skhs.pl

Tender Details

Medicinal product siltuximab as part of the B.131 Drug Program - 35 packages
The announcement concerns: Public procurement
Type of order: Supplies
CPV Descriptions: Pharmaceutical products

Documents

Tender Notice

Browse More

All Tenders From Poland

All Tenders From Europe

Want To Bid in This Tender?

Get Local Agent Support in Poland and 60 More Countries.

View All The Services

View Tenders By

Publish Tenders

Superior Approach, High ROI

Instantneous Global Reach